# A Study to Evaluate a PIKA Rabies Vaccine（Vero Cell）for Human Use,Freeze-dried

> **NCT05667974** · PHASE3 · UNKNOWN · sponsor: **Yisheng Biopharma (Singapore) Pte. Ltd.** · enrollment: 4500 (actual)

## Conditions studied

- Rabies
- Prevention

## Interventions

- **BIOLOGICAL:** PIKA Rabies Vaccine (Vero Cell) for Human use, Freeze-dried
- **BIOLOGICAL:** Chirorab

## Key facts

- **NCT ID:** NCT05667974
- **Lead sponsor:** Yisheng Biopharma (Singapore) Pte. Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-09-22
- **Primary completion:** 2024-03-22
- **Final completion:** 2025-02-21
- **Target enrollment:** 4500 (ACTUAL)
- **Last updated:** 2024-07-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05667974

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05667974, "A Study to Evaluate a PIKA Rabies Vaccine（Vero Cell）for Human Use,Freeze-dried". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05667974. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*